Trial intelligence / Profile preview

Impact of thermo-mechanical intervention on Protoporphyrin IX accumulation after topical 5-aminolevulinic acid

2018-004397-96Phase 2Completed

Sponsor
Merete Hædersdal
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of 5-aminolevulinic acid (2 arms), sponsored by Merete Hædersdal. Primary endpoints: PpIX fluorescence intensity at skin surface and PpIX fluorescence intensity and biodistribution within skin. Started Jan 2019; status: completed.

02

Drugs

5-aminolevulinic acid

Beyond the preview

Go deeper on 2018-004397-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004397-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call